RT Journal Article
SR Electronic
T1 A Deep Ensemble Encoder Network Method for Improved Polygenic Risk Score Prediction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.31.24311311
DO 10.1101/2024.07.31.24311311
A1 Ozdemir, Okan B
A1 Chen, Ruining
A1 Li, Ruowang
YR 2024
UL http://medrxiv.org/content/early/2024/08/02/2024.07.31.24311311.abstract
AB Genome-wide association studies (GWAS) of various heritable human traits and diseases have identified numerous associated single nucleotide polymorphisms (SNPs), most of which have small or modest effects. Polygenic risk scores (PRS) aim to better estimate individuals' genetic predisposition by aggregating the effects of multiple SNPs from GWAS. However, current PRS is designed to capture only simple linear genetic effects across the genome, limiting their ability to fully account for the complex polygenic architecture. To address this, we propose DeepEnsembleEncodeNet (DEEN), a new method that ensembles autoencoders and fully connected neural networks (FCNNs) to better identify and model linear and non-linear SNP effects across different genomic regions, improving its ability to predict disease risks. To demonstrate DEEN's performance, we optimized the model across binary and continuous traits from the UK Biobank (UKBB). Model evaluation on the held-out UKBB testing dataset, as well as the independent All of Us (AoU) dataset, showed improved prediction and risk stratification, consistently outperforming other methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementR.L is supported in part by Cedars Sinai Department of Neurology/Jona Goldrich Center for Alzheimer's & Memory Disorders. O.B.O, R.C, and R.L are supported by the Department of Computational Biomedicine, Cedars Sinai.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UKBB is a large-scale biomedical database with genetic and health information from more than 500,000 UK participants. Available for research by request at https://www.ukbiobank.ac.uk. The UKBB data was approved under application # 86494 The All of Us Research Program is a large-scale biomedical database with diverse health data from over one million U.S. participants. Available for research by request at this link: https://www.researchallofus.org/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe UKBB is a large-scale biomedical database with genetic and health information from more than 500,000 UK participants. Available for research by request at https://www.ukbiobank.ac.uk. The UKBB data was approved under application # 86494 The All of Us Research Program is a large-scale biomedical database with diverse health data from over one million U.S. participants. Available for research by request at this link: https://www.researchallofus.org/https://www.researchallofus.org/https://www.ukbiobank.ac.uk